Proposal to amend regulatory and funding restrictions for ADHD treatments

Our response to Pharmac's proposal to change the regulatory and funding restrictions for stimulant treatments for ADHD.

The Mental Health Foundation of New Zealand supports equitable access to assessment and support for ADHD and other neurodevelopmental disorders. We support the submission of ADHD New Zealand on this proposal, including their recommendations for making the prescribing model for ADHD as effective as possible.